Alyeska Investment Group, L.P. Acadia Pharmaceuticals Inc Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $8.88 Million - $15.4 Million	-499,340 Reduced 85.35%	85,696 $1.58 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $12.2 Million - $18.6 Million	585,036 New	585,036 $18.3 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $6.29 Million - $10.1 Million	-439,166 Reduced 71.51%	175,000 $2.83 Million
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $928,819 - $1.34 Million	-41,336 Reduced 6.31%	614,166 $13.8 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $7.77 Million - $11.3 Million	289,583 Added 79.14%	655,502 $19.7 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $10.8 Million - $14 Million	365,919	365,919 $13.8 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.